| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 1.437.307 | 3.178.734 | 4.248.114 | 4.877.230 |
| Total Income - EUR | - | - | - | - | - | 0 | 1.437.307 | 3.179.289 | 4.248.118 | 4.877.230 |
| Total Expenses - EUR | - | - | - | - | - | 196 | 1.421.622 | 3.166.560 | 4.213.600 | 4.829.200 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -196 | 15.684 | 12.730 | 34.519 | 48.030 |
| Net Profit/Loss - EUR | - | - | - | - | - | -196 | 1.871 | 10.403 | 28.963 | 40.343 |
| Employees | - | - | - | - | - | 0 | 3 | 0 | 5 | 2 |
Check the financial reports for the company - Fresh Bio Innovation S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 881 | 2.840.930 | 2.834.526 |
| Current Assets | - | - | - | - | - | 118 | 132.532 | 353.302 | 510.729 | 620.184 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 106.709 | 186.816 | 496.645 | 609.445 |
| Cash | - | - | - | - | - | 118 | 25.823 | 166.486 | 14.084 | 10.739 |
| Shareholders Funds | - | - | - | - | - | -113 | 1.761 | 12.169 | 41.095 | 81.209 |
| Social Capital | - | - | - | - | - | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 231 | 130.771 | 342.014 | 3.310.564 | 3.373.501 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Fresh Bio Innovation S.r.l.